Compare, Analyse AANJANEYA LIFECARE with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ADCOCK INGRAM
Jun-14
DR. DATSONS LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs126373-   
Low Rs31269-   
Sales per share (Unadj.) Rs133.0111.1-  
Earnings per share (Unadj.) Rs0.2-28.0-  
Cash flow per share (Unadj.) Rs6.6-23.2-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.887.2-  
Shares outstanding (eoy) m31.66168.78-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.9 20.3%   
Avg P/E ratio x516.1-11.5 -4,494.8%  
P/CF ratio (eoy) x11.8-13.9 -85.5%  
Price / Book Value ratio x0.63.7 16.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47754,239 4.6%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m563,404 1.6%   
Avg. sales/employee Rs ThNM4,366.6-  
Avg. wages/employee Rs ThNM793.0-  
Avg. net profit/employee Rs ThNM-1,100.3-  
INCOME DATA
Net Sales Rs m4,21118,746 22.5%  
Other income Rs m79131 60.0%   
Total revenues Rs m4,28918,877 22.7%   
Gross profit Rs m569-3,249 -17.5%  
Depreciation Rs m204809 25.3%   
Interest Rs m430508 84.7%   
Profit before tax Rs m13-4,434 -0.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6277 2.2%   
Profit after tax Rs m5-4,724 -0.1%  
Gross profit margin %13.5-17.3 -77.9%  
Effective tax rate %48.0-6.2 -768.7%   
Net profit margin %0.1-25.2 -0.5%  
BALANCE SHEET DATA
Current assets Rs m6,85213,730 49.9%   
Current liabilities Rs m6,7117,725 86.9%   
Net working cap to sales %3.332.0 10.5%  
Current ratio x1.01.8 57.4%  
Inventory Days Days161111 145.0%  
Debtors Days Days318124 257.0%  
Net fixed assets Rs m3,6738,003 45.9%   
Share capital Rs m31787 363.8%   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,07814,714 27.7%   
Long term debt Rs m1,6715,171 32.3%   
Total assets Rs m12,63327,795 45.4%  
Interest coverage x1.0-7.7 -13.3%   
Debt to equity ratio x0.40.4 116.6%  
Sales to assets ratio x0.30.7 49.4%   
Return on assets %3.4-15.2 -22.7%  
Return on equity %0.1-32.1 -0.4%  
Return on capital %7.7-19.8 -38.7%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,3451,600 84.0%  
From Investments Rs m-2,256-491 459.1%  
From Financial Activity Rs m-1,2004,693 -25.6%  
Net Cashflow Rs m-2,1115,801 -36.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.15 Rs / ZAR

Compare DR. DATSONS LABS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: ALKEM LABORATORIES  SUVEN LIFE SCIENCES  ORCHID PHARMA  TTK HEALTHCARE  ALEMBIC PHARMA  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views On News

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This... (Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun (Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel Views On News (Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS